Hahn, E.; Rodin, D.; Sutradhar, R.; Nofech-Mozes, S.; Trebinjac, S.; Paszat, L.F.; Rakovitch, E.
Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS? Curr. Oncol. 2023, 30, 5795-5806.
https://doi.org/10.3390/curroncol30060433
AMA Style
Hahn E, Rodin D, Sutradhar R, Nofech-Mozes S, Trebinjac S, Paszat LF, Rakovitch E.
Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS? Current Oncology. 2023; 30(6):5795-5806.
https://doi.org/10.3390/curroncol30060433
Chicago/Turabian Style
Hahn, Ezra, Danielle Rodin, Rinku Sutradhar, Sharon Nofech-Mozes, Sabina Trebinjac, Lawrence Frank Paszat, and Eileen Rakovitch.
2023. "Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?" Current Oncology 30, no. 6: 5795-5806.
https://doi.org/10.3390/curroncol30060433
APA Style
Hahn, E., Rodin, D., Sutradhar, R., Nofech-Mozes, S., Trebinjac, S., Paszat, L. F., & Rakovitch, E.
(2023). Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS? Current Oncology, 30(6), 5795-5806.
https://doi.org/10.3390/curroncol30060433